Louis Provencher

Learn More
Tamoxifen (TAM), the only antiestrogen currently available for the endocrine therapy of breast cancer behaves as a mixed agonist/antagonist of estrogen action, thus limiting its therapeutic potential. We report the binding characteristics of a novel series of nonsteroidal antiestrogens to the rat uterine estrogen receptor. As measured by competition(More)
Historic fire suppression and intensive forest management in longleaf pine (Pinus palustris) sandhill forests has resulted in hardwood encroachment and degradation of this fire-dependent ecosystem. Active management is now required to restore native community structure and composition, but little is known about the long-term impacts of typical restoration(More)
The nonsteroidal antiestrogen EM-800 is approximately 10-fold more potent than ICI 182 780, the most potent known steroidal antiestrogen, at inhibiting estrone-stimulated uterine weight in ovariectomized mice (half-maximal inhibitory daily s.c. doses of 0.2 and 2.0 microg, respectively). At maximal doses, however, both compounds lead to a similar maximal(More)
  • 1